Provided by Tiger Trade Technology Pte. Ltd.

Evogene

0.4356
+0.03859.70%
Post-market: 0.4284-0.0072-1.65%17:20 EDT
Volume:768.24K
Turnover:329.65K
Market Cap:6.88M
PE:-0.48
High:0.4700
Open:0.3800
Low:0.3800
Close:0.3971
52wk High:1.50
52wk Low:0.3521
Shares:15.80M
Float Shares:14.46M
Volume Ratio:0.05
T/O Rate:5.31%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.9012
EPS(LYR):-1.0776
ROE:-182.75%
ROA:-37.53%
PB:-2.09
PE(LYR):-0.40

Loading ...

Major Insider Move Signals Growing Confidence in Evogene

TIPRANKS
·
Aug 14

Evogene Director Leon Recanati Acquires 460,000 Shares Worth $292,100

Reuters
·
Aug 13

Major Insider Move: Evogene Director Makes Bold Share Grab

TIPRANKS
·
Aug 06

Evogene Director Leon Recanati Buys 800,000 Shares for $400,000

Reuters
·
Aug 06

Evogene Sets Sept. 4 AGM Amid Board Contest and VP Departure

TIPRANKS
·
Aug 01

Evogene Announces Annual Shareholder Meeting

Reuters
·
Aug 01

Evogene to Release Q2 2026 Financial Results

Reuters
·
Jul 30

Evogene, ELEO Collaborate to Develop Oral Small-molecule PCSK9 Inhibitors for Hyperlipidemia

Reuters
·
Jul 22

Evogene Expands ATM Offering as Shareholder Activism Escalates

TIPRANKS
·
Jul 18

Agplenus Launches AI Model to Predict Antifungal Potency, Expands Chempass AI for Ag Platform

Reuters
·
Jul 15

Evogene, BCDD announces strategic joint initiative

TIPRANKS
·
Jul 08

Evogene Partners with Tel Aviv University Drug Discovery Center on Ai-driven Small-molecule R&D

Reuters
·
Jul 08

Evogene achieves integration of agentic systems with ChemPass AI platform

TIPRANKS
·
Jun 24

Evogene, Google Cloud Integrate Agentic AI into Chempass Platform in Expanded Collaboration

Reuters
·
Jun 24

Evogene Sets Up $2.9 Million At-the-Market Share Offering With A.G.P.

TIPRANKS
·
Jun 12

Evogene enters ATM equity sales agreement for up to $2.93 million offering

Reuters
·
Jun 12

Evogene to present pharma division achievements at BIO International Convention

Reuters
·
Jun 09

Evogene Announces Successful Completion Of Phase 1 Clinical Study Of Bmc128, A Rationally Designed Live Bacterial Product, In Combination With Nivolumab By Its Subsidiary Biomica

Reuters
·
Jun 02

Evogene completes Phase 1 trial of Biomica’s BMC128 plus Bristol-Myers’ Opdivo in advanced solid tumors

Reuters
·
Jun 02

Analysts Are Bullish on These Healthcare Stocks: Evogene (EVGN), NanoViricides (NNVC)

TIPRANKS
·
May 27